PortfoliosLab logoPortfoliosLab logo
TWST vs. ASPN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TWST vs. ASPN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Twist Bioscience Corporation (TWST) and Aspen Aerogels, Inc. (ASPN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TWST achieves a 168.51% return, which is significantly higher than ASPN's 125.09% return.


TWST

1D
-2.73%
1M
40.61%
YTD
168.51%
6M
142.93%
1Y
145.87%
3Y*
70.18%
5Y*
-6.65%
10Y*

ASPN

1D
0.79%
1M
10.02%
YTD
125.09%
6M
118.90%
1Y
10.02%
3Y*
-3.23%
5Y*
-23.74%
10Y*
2.98%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TWST vs. ASPN - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
TWST
Twist Bioscience Corporation
168.51%-31.74%26.07%54.81%-69.23%-45.23%572.81%-9.05%77.62%
ASPN
Aspen Aerogels, Inc.
125.09%-76.18%-24.71%33.84%-76.32%198.32%115.08%264.32%-45.52%

Correlation

The correlation between TWST and ASPN is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.36

Correlation (5Y)
Calculated over the trailing 5-year period

0.41

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2018

0.34

The correlation between TWST and ASPN shifts across timeframes, from 0.29 (1 year) to 0.41 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

TWST:

$5.26B

ASPN:

$527.07M

EPS

TWST:

-$1.33

ASPN:

-$1.36

PS Ratio

TWST:

12.71

ASPN:

2.28

PB Ratio

TWST:

11.55

ASPN:

2.47

Total Revenue (TTM)

TWST:

$409.48M

ASPN:

$230.26M

Gross Profit (TTM)

TWST:

$213.23M

ASPN:

$27.46M

EBITDA (TTM)

TWST:

-$58.23M

ASPN:

-$59.70M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TWST vs. ASPN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TWST
TWST Risk / Return Rank: 8686
Overall Rank
TWST Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
TWST Sortino Ratio Rank: 8686
Sortino Ratio Rank
TWST Omega Ratio Rank: 8282
Omega Ratio Rank
TWST Calmar Ratio Rank: 8888
Calmar Ratio Rank
TWST Martin Ratio Rank: 8484
Martin Ratio Rank

ASPN
ASPN Risk / Return Rank: 4848
Overall Rank
ASPN Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
ASPN Sortino Ratio Rank: 5151
Sortino Ratio Rank
ASPN Omega Ratio Rank: 5555
Omega Ratio Rank
ASPN Calmar Ratio Rank: 4545
Calmar Ratio Rank
ASPN Martin Ratio Rank: 4444
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TWST vs. ASPN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Twist Bioscience Corporation (TWST) and Aspen Aerogels, Inc. (ASPN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TWSTASPNDifference
Sharpe ratioReturn per unit of total volatility

+2.09

Sortino ratioReturn per unit of downside risk

+1.90

Omega ratioGain probability vs. loss probability

1.31

1.13

+0.19

Calmar ratioReturn relative to maximum drawdown

3.84

0.14

+3.70

Martin ratioReturn relative to average drawdown

8.14

0.22

+7.92

TWST vs. ASPN - Sharpe Ratio Comparison

The current TWST Sharpe Ratio is 2.20, which is higher than the ASPN Sharpe Ratio of 0.11. The chart below compares the historical Sharpe Ratios of TWST and ASPN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TWST vs. ASPN - Drawdown Comparison

The maximum TWST drawdown since its inception was -94.48%, roughly equal to the maximum ASPN drawdown of -95.96%. Use the drawdown chart below to compare losses from any high point for TWST and ASPN.


Loading charts...

Drawdown Indicators


TWSTASPNDifference

Max Drawdown

Largest peak-to-trough decline

-94.48%

-95.96%

+1.48%

Max Drawdown (1Y)

Largest decline over 1 year

-38.24%

-70.86%

+32.62%

Max Drawdown (3Y)

Largest decline over 3 years

-58.97%

-91.90%

+32.93%

Max Drawdown (5Y)

Largest decline over 5 years

-91.54%

-95.96%

+4.42%

Max Drawdown (10Y)

Largest decline over 10 years

-95.96%

Current Drawdown

Current decline from peak

-59.05%

-89.99%

+30.94%

Average Drawdown

Average peak-to-trough decline

-58.15%

-56.50%

-1.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.99%

45.65%

-27.66%

Volatility

TWST vs. ASPN - Volatility Comparison

Twist Bioscience Corporation (TWST) and Aspen Aerogels, Inc. (ASPN) have volatilities of 19.89% and 19.67%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TWSTASPNDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.89%

19.67%

+0.22%

Volatility (6M)

Calculated over the trailing 6-month period

48.60%

65.65%

-17.05%

Volatility (1Y)

Calculated over the trailing 1-year period

66.98%

92.76%

-25.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

75.93%

88.01%

-12.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.40%

74.97%

+3.43%

Dividends

TWST vs. ASPN - Dividend Comparison

Neither TWST nor ASPN has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TWST vs. ASPN - Financials Comparison

This section allows you to compare key financial metrics between Twist Bioscience Corporation and Aspen Aerogels, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00M40.00M60.00M80.00M100.00M120.00M20222023202420252026
110.72M
37.88M
(TWST) Total Revenue
(ASPN) Total Revenue
Values in USD except per share items

TWST vs. ASPN - Profitability Comparison

The chart below illustrates the profitability comparison between Twist Bioscience Corporation and Aspen Aerogels, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-60.0%-40.0%-20.0%0.0%20.0%40.0%60.0%20222023202420252026
51.6%
11.3%
Portfolio components
TWST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Twist Bioscience Corporation reported a gross profit of 57.12M and revenue of 110.72M. Therefore, the gross margin over that period was 51.6%.

ASPN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aspen Aerogels, Inc. reported a gross profit of 4.28M and revenue of 37.88M. Therefore, the gross margin over that period was 11.3%.

TWST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Twist Bioscience Corporation reported an operating income of -45.86M and revenue of 110.72M, resulting in an operating margin of -41.4%.

ASPN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aspen Aerogels, Inc. reported an operating income of -20.83M and revenue of 37.88M, resulting in an operating margin of -55.0%.

TWST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Twist Bioscience Corporation reported a net income of -44.02M and revenue of 110.72M, resulting in a net margin of -39.8%.

ASPN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aspen Aerogels, Inc. reported a net income of -23.69M and revenue of 37.88M, resulting in a net margin of -62.5%.


Frequently Asked Questions


TWST and ASPN have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TWST has higher volatility (19.89%) compared to ASPN (19.67%). In terms of maximum drawdown, TWST dropped -94.48% vs ASPN's -95.96%.

TWST currently has the higher Sharpe Ratio (2.20 vs 0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TWST and ASPN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer